Drugs target to NCBP2

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
OBEFAZIMODSmall moleculeulcerative colitisCap binding complex modulator2.0RecruitingClinicalTrials
OBEFAZIMODSmall moleculeulcerative colitisCap binding complex modulator2.0Active, not recruitingClinicalTrials
OBEFAZIMODSmall moleculeulcerative colitisCap binding complex modulator2.0CompletedClinicalTrials
OBEFAZIMODSmall moleculeulcerative colitisCap binding complex modulator3.0RecruitingClinicalTrials
OBEFAZIMODSmall moleculeHIV infectionCap binding complex modulator1.0CompletedClinicalTrials
OBEFAZIMODSmall moleculeCOVID-19Cap binding complex modulator2.0TerminatedClinicalTrials
OBEFAZIMODSmall moleculerheumatoid arthritisCap binding complex modulator2.0CompletedClinicalTrials
OBEFAZIMODSmall moleculerheumatoid arthritisCap binding complex modulator2.0Active, not recruitingClinicalTrials
OBEFAZIMODSmall moleculeHIV infectionCap binding complex modulator2.0CompletedClinicalTrials
OBEFAZIMODSmall moleculeulcerative colitisCap binding complex modulator3.0Not yet recruitingClinicalTrials
OBEFAZIMODSmall moleculeCrohn's diseaseCap binding complex modulator2.0Not yet recruitingClinicalTrials